PCI with everolimus-eluting stents was noninferior to CABG for death, stroke, or myocardial infarction at 3 years in patients with left main coronary disease.
Does PCI with everolimus-eluting stents improve the composite end point of death, stroke, or myocardial infarction at 3 years in patients with left main coronary artery disease and low or intermediate SYNTAX scores compared to CABG?
In patients with left main coronary artery disease and low or intermediate SYNTAX scores, PCI with everolimus-eluting stents is noninferior to CABG for the composite outcome of death, stroke, or MI at 3 years.
Absolute Event Rate: 0% vs 0%
In patients with left main coronary artery disease and low or intermediate SYNTAX scores by site assessment, PCI with everolimus-eluting stents was noninferior to CABG with respect to the rate of the composite end point of death, stroke, or myocardial infarction at 3 years. (Funded by Abbott Vascular; EXCEL ClinicalTrials.gov number, NCT01205776 .).
Stone et al. (Mon,) reported a other. PCI with everolimus-eluting stents was noninferior to CABG for death, stroke, or myocardial infarction at 3 years in patients with left main coronary disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: